Академический Документы
Профессиональный Документы
Культура Документы
29 31 MAY 2006
I.
Monday 29 May 2006
Opening and welcome
Mr. Radim Blha, director of Direct Taxes Administration Department, opened the seminar and welcomed all participants to Prague on behalf of Ministry of Finance of the Czech Republic. Then Mr. Blha forwarded the speech to the Director General of Central Tax Directorate, Mr. Jan Knek, who also welcomed all delegates from European tax administrations, representatives of private sector and delegates of the European Commission and pointed out the importance of the Fiscalis seminar, which contributed to gaining better knowledge of transfer pricing and intangible property issues and which allowed participants to exchange their valuable experiences. Mr. Jean-Marc Van Leeuw and Mr. Edward Morris from the European Commission then welcomed all delegates on behalf of the Commission and expressed the hope of the usefulness of the seminar performed on such current issue. They briefly described the current situation in the field of intangible property and mentioned the advantage of having also representatives of business participating, which should help to better understanding between tax administrations and private sector.
a) capital
if one person directly or indirectly shares in capital or voting rights of other person, limit min. 25%
b) other relationships
one person participates in management or control of other person the same persons or close persons participate in management or control of other persons controlling and controlled companies related natural persons a relationship created for purpose to reduce taxable profit or to increase loss The Czech Tax Administration has issued three main guidelines related to transfer pricing, which describes so called best practice - not legally binding but commonly used by both taxpayers and tax administration. D-258 (January 2004) How to apply OECD Guidelines within the Czech Republic D-292 (January 2006) Binding opinion for pricing of transactions between related parties, based on the APA principals D-293 (January 2006) Documentation based on Code of Conduct issued by EU JTPF
divided IPR into several categories: patents, mini patents, copyrights, compilations (computer programs, etc.). He introduced system of registration of IP in UK and procedure of application for a patent. Subsequently Mr Engelman presented the fundamental issues concerning transfer of IPR and the legal implications of offshore transfers of trademark rights. One theme became clear: that it was not always legally possible to separate IPR from the underlying physical assets that had helped to create the IPR in the first place.
Embedded vs Fragmented Intangible Property A Case Study applying International TP in the Ethical Pharmaceutical Industry
Mr. Wndisch, specialist from the core of pharmaceutical industry, introduced the particular transfer pricing challenges and the special risks of the pharmaceutical and biotech industry as a sector with intangible assets of a great value. He resumed why CUP or COST+ methods are practically not applicable to Pharma/Biotech industry (COST+ can be used in contractual manufacturing) and that RPM is likely to be the only applicable method to negotiate transfer prices for Pharma/Biotech products. In the second half of his presentation, Mr. Wndisch presented a case study concerning the typical Pharma/Biotech industry MNEs business model. He explained to representatives of European tax administrations the basics of the business model of pharmaceutical companies using contract manufacturing with consignment stocks. He drew their attention to the problem of a time gap between the moment when tax for IP is due and the moment of real profit realising if the owner of IP has to sell active ingredient to the manufacturer within intragroup transactions. He proposed a conclusion, which would bring transparent and defendable TP system with no sale of active ingredients, using COST+ method for manufacturing and RPM for finished products including intangibles. For Pharma/Biotech enterprises the protection of intellectual property rights is their lifeline. Private financing of high risk R&D can only then be expected.
appropriate TP methodology reflecting the real allocation of assets, risks and functions. Mr Clarck mentioned that very often a suitable CUP cant be identified, particularly where rare intangibles are involved. If there is a question of attributing profit to valuable intangibles, profit split method is usually suitable.